NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, Feb. 18, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. (“Neumora” or “the Company”) NMRA for violations of the federal securities laws. Investors who purchased the Company’s securities pursuant and/or traceable to the Company’s Offering Documents in ...









